Skip to main content

darunavir

Generic: DARUNAVIR·Brand: DARUNAVIR, PREZISTA, Prezcobix, Prezista, Symtuza

darunavir: 2 clinical trials tracked.

darunavir evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about darunavir, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

HIV Infections
Clinical Trials (2)

Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)

NCT01641367·Phase 4·TGTX
Completed

Primary endpoint: Proportion of Participants With Plasma HIV-1 RNA ≤200 Copies/mL at 48 Weeks

InterventionalRandomizedopen545 enrolledStarted 2013-02Completion 2018-1219 sites · Brazil, Haiti, India, Kenya…Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

A Randomized Multicenter Study With Non-inferiority Hypothesis, Comparing the Availability to Maintain a Complete Viral Suppression by a Monotherapy of Darunavir/r to a NRTI Containing Regimen Including Darunavir/r, in HIV-1 Infected Patients With Previous Prolonged Complete Viral Suppression. ANRS 136 MONOI

NCT00421551·Phase 3
Completed

Primary endpoint: Proportion of patients with virological success, the virological failure is defined as 2 consecutive plasma viral load measurements greater or equal to 400 cp/ml within 2 weeks at W48

InterventionalRandomizedopen225 enrolledStarted 2007-03Completion 2011-021 site · FranceFrench National Agency for Research on AIDS and Viral Hepatitis